SCHEMBL2650677

SCHEMBL2650677

OCCCc1ccc(C2OCCO2)c2ccccc12

nearest known ligand 0.35

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.35
KDM4E B2RXH2 1/20 0.33
SLC22A12 Q96S37 1/20 0.31
CNR2 P34972 2/20 0.31
BRD1 O95696 1/20 0.30
TAF1 P21675 1/20 0.30
BRPF1 P55201 1/20 0.30
TAF1L Q8IZX4 1/20 0.30
CREBBP Q92793 1/20 0.30
CECR2 Q9BXF3 1/20 0.30
BRPF3 Q9ULD4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17537709 0.78 POLB (0.47) POLBKDM4EBRD1TAF1BRPF1
SCHEMBL2648820 0.78 SLC6A4 (0.34) SLC22A12
SCHEMBL9518709 0.75 CYSLTR2 (0.37)
SCHEMBL17537710 0.74 POLB (0.45) POLBKDM4E
SCHEMBL17537960 0.74 POLB (0.45) POLBKDM4EBRD1TAF1BRPF1
SCHEMBL17537711 0.74 POLB (0.45) POLBKDM4EBRD1TAF1BRPF1
SCHEMBL11648609 0.74 POLB (0.43) POLBKDM4EBRD1TAF1BRPF1
SCHEMBL2648604 0.73 CYP4F2 (0.52) POLBKDM4E
SCHEMBL17537958 0.73 POLB (0.44) POLBKDM4EBRD1TAF1BRPF1
SCHEMBL17537712 0.72 POLB (0.42) POLBKDM4EBRD1TAF1BRPF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6613942-B1 Nonpeptide; 4-hydroxy benzoic acid hydrazides NOVO NORDISK A/S (DK) 2003-09-02 US disclosed
EP-0994848-A1 GLUCAGON ANTAGONISTS/INVERSE AGONISTS NOVO NORDISK A/S (DK) 2000-04-26 EP disclosed
WO-1999001423-A1 GLUCAGON ANTAGONISTS/INVERSE AGONISTS NOVO NORDISK A/S (DK) 1999-01-14 WO disclosed
WO-1999001423-A1 GLUCAGON ANTAGONISTS/INVERSE AGONISTS NOVO NORDISK A/S (DK) 1999-01-14 WO disclosed